Heart specific RNase Z variants show a mild decrease in longevity and locomotor response. by Ekaterina Migunova (15909887)

Correlation between decrease in methylation levels and increase in t-PA expression. by Mia Magnusson (182244)

PAM16 correlation with N-MYC. by Zahra Motahari (6814013)

Ivermectin significantly decreases <i>L</i>. <i>loa</i> mf in BALB/c mice. by Rene Bilingwe Ayiseh (6900296)

FSS rescues homocysteine-caused the decrease of NO production in cultured HUVECs after the application of A23187. by Cathy W. C. Bi (108697)

Adult Size Decreases with Increasing Mit Mutant RNAi Concentration by Shane L Rea (34987)

(<i>S</i>)-PZQ decrease tone of contracted mesenteric arteries. by Gihan S. Gunaratne (5117795)

Percent of land use during the BASE20 and HG-2 (MRI SSP5) scenario along with corresponding mean annual TSS concentration values (mg/L) across all intake locations. by Elly T. Gay (21170097)

Stress can increase or decrease anxiety depending on the timing of the stressor by Jason Snyder (96580)

Fig 5 - by Te-Hsing Hsu (16973374)

Probucol prevents 3-NP-induced decreases in body weight. by Dirleise Colle (422124)

Comparison of the decrease rate of IP-10 and VEGF in TB+HIV by Catherine Riou (164842)

Meningococcal adhesion on endothelial cells is required to decrease EPCR expression. by Hervé Lécuyer (5076971)

Glutamate excitotoxicity decreases viability of cultured hippocampal GABAergic neurons. by Márcio S. Baptista (365618)

Discrimination performance deteriorated as the safe-to-conditioned ΔF decreased. by Chi Chen (67021)

RL2 decreases viability and induces apoptosis in cultured cells. by Olga A. Koval (548122)

Uric acid treatment decreases glucose-stimulated insulin secretion. by Lu Jia (295253)

RES decreases TG accumulation in ethanol-fed rat livers. by Zhenhua Ma (4344910)

Basal IKK activity is decreased in cells lacking IRE1. by Arvin B. Tam (124164)

Acute JMV2959 treatment decreases alcohol preference in rats. by Petra Suchankova (400313)

“…<p>(A) Acute administration of the GHS-R1A antagonist JMV2959 (1 or 3 mg/kg) decreases the alcohol preference compared to vehicle at 1 hour time interval in rats voluntarily consuming alcohol for two and five months before the treatment. …”